CLINICAL_TRIALS
trial_result
· 2023-09-26
Clinical Trial Update: A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia [Phase 1]
Summary
A Phase 1 trial assessing a single IV dose of TAK-925 in participants with idiopathic hypersomnia has completed with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Idiopathic Hypersomnia | Phase 1 | Status: COMPLETED | Results posted: 2023-09-26